advertisement-vertical Download Proto magazine app
Social Icons

Drugs: In the Pipeline

Researchers and drugmakers have high hopes for many new monoclonal antibodies. These four are undergoing human testing or awaiting regulatory review by the FDA.

By Lauren Ware // Fall 2012
icon-printprint
share: digg.com del.icio.us facebook.com

icon-printprint
share: digg.com del.icio.us facebook.com
Protomag on Facebook Protomag on Twitter